AN1 0.00% 0.8¢ anagenics limited

Is this it?

  1. 78 Posts.
    Major pharmaceutical companies are racing to launch breakthrough drugs to treat advanced melanoma, the deadliest form of skin cancer.

    These majors include:

    Bristol-Myers Squibb

    Roche Holding

    Merck

    AstraZeneca



    I wonder which of these four will be the first in making a call to Cellmid & Co.

    The mind boggles when looking at the $'s on offer for a ground breaking new drugs.

    The above four are no different to other any other food, engineering or manufacturing businesses; they need new innovative products to grow revenue streams and be a market leader

    Well, Midkine can possibly provide that opportunity.
 
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
(20min delay)
Last
0.8¢
Change
0.000(0.00%)
Mkt cap ! $3.690M
Open High Low Value Volume
0.8¢ 0.8¢ 0.8¢ $336 42K

Buyers (Bids)

No. Vol. Price($)
3 1457234 0.8¢
 

Sellers (Offers)

Price($) Vol. No.
0.9¢ 340000 1
View Market Depth
Last trade - 14.19pm 12/07/2024 (20 minute delay) ?
AN1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.